|Articles|November 1, 1998

November 1998
Volume 4
Issue 11

Explaining Price Variations for the Inpatient Treatment of Congestive Heart Failure

Author(s)John A. Rizzo, PhD, W. Robert Simons, MA

Download PDF: Explaining Price Variations for the Inpatient Treatment of Congestive Heart Failure

Articles in this issue

over 27 years ago

Article

Discontinuity of Care: Urgent Care Utilization Within a Health Maintenance Organization

over 27 years ago

Article

Consequences of Intermittent Treatment for Hypertension: The Case for Medication Compliance and Persistence

over 27 years ago

Article

The Ethical Dilemma of Population-Based Medical Decision Making

over 27 years ago

Article

Efficacy, Safety, and Impact on Quality of Life of Salmeterol in Patients With Moderate Persistent Asthma

over 27 years ago

Article

Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer

over 27 years ago

Article

Ventricular Arrhythmias and the Use of Antiarrhythmic Drugs After Cardiovascular Surgery

over 27 years ago

Article

Methods of Evaluation in Outcomes Research

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Explaining Price Variations for the Inpatient Treatment of Congestive Heart Failure

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

How MCOs Should Be Preparing for the OBBBA's Medicaid Cuts: David Brueggeman, MBA

Early Data Show Revumenib Offers Maintenance Option in AML Following SCT